[go: up one dir, main page]

TN2013000154A1 - Silent fc variants of anti-cd40 antibodies - Google Patents

Silent fc variants of anti-cd40 antibodies

Info

Publication number
TN2013000154A1
TN2013000154A1 TNP2013000154A TN2013000154A TN2013000154A1 TN 2013000154 A1 TN2013000154 A1 TN 2013000154A1 TN P2013000154 A TNP2013000154 A TN P2013000154A TN 2013000154 A TN2013000154 A TN 2013000154A TN 2013000154 A1 TN2013000154 A1 TN 2013000154A1
Authority
TN
Tunisia
Prior art keywords
antibodies
silent
variants
disorders
transplantation
Prior art date
Application number
TNP2013000154A
Other languages
French (fr)
Inventor
Christoph Heusser
James Rush
Karen Vincent
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/070058 external-priority patent/WO2012065950A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2013000154A1 publication Critical patent/TN2013000154A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to silent Fc variants of anti-CD40 antibodies and compositions and methods of use of said antibodies for treating pathological disorders such as autoimmune and inflammatory disorders and/or for preventing or reducing the risk of graft rejection in transplantation.
TNP2013000154A 2011-11-14 2013-04-08 Silent fc variants of anti-cd40 antibodies TN2013000154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/070058 WO2012065950A1 (en) 2010-11-15 2011-11-14 Silent fc variants of anti-cd40 antibodies

Publications (1)

Publication Number Publication Date
TN2013000154A1 true TN2013000154A1 (en) 2014-11-10

Family

ID=54360596

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000154A TN2013000154A1 (en) 2011-11-14 2013-04-08 Silent fc variants of anti-cd40 antibodies

Country Status (1)

Country Link
TN (1) TN2013000154A1 (en)

Similar Documents

Publication Publication Date Title
PH12013500973A1 (en) Silent fc variants of anti-cd40 antibodies
EP3725811A3 (en) Compositions for inhibiting masp-2 dependent complement activation
IN2014CN04765A (en)
PH12017500864A1 (en) Anti-notch1 antibodies
PH12013500564A1 (en) Anti-cd48 antibodies and uses thereof
WO2012012737A3 (en) Stable tregs and related materials and methods
MX356107B (en) Histidyl-trna synthetases for treating autoimmune and inflammatory diseases.
MX349886B (en) Anti-pseudomonas psl binding molecules and uses thereof.
NZ702334A (en) New diazaspirocycloalkane and azaspirocycloalkane
MY178142A (en) Anti-phf-tau antibodies and their uses
MX2015012551A (en) Anti-cd25 antibodies and their uses.
MX2018009524A (en) Arginine - free tnfr : fc- fusion polypeptide compositions and methods of use.
MX354955B (en) Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists.
MX2014000142A (en) Use of anti-cd83 agonist antibodies for treating autoimmune diseases.
MX356163B (en) Substituted anilines as ccr(4) antagonists.
MX2015012563A (en) Anti-cd25 antibodies and their uses.
PH12012500828A1 (en) Compositions and methods for treating inflammatory disorders
WO2013023059A3 (en) Methods and compositions for the treatment of autoimmune and inflammatory diseases
IN2014DN00254A (en)
MX363385B (en) Treatment of sickle cell disease and inflammatory conditions.
MX361773B (en) Tlr3 binding agents.
WO2012095432A3 (en) Tlr3 binding agents
TN2013000154A1 (en) Silent fc variants of anti-cd40 antibodies
TN2011000041A1 (en) Compositions and methods for antibodies targeting complement protein c5